Sign in
4/A

Changes in Ownership

Alkermes plc. Filed Acc 0001127602-21-001769

EVP R&D, Chief Medical Officer acquired 6,875 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Hopkinson Craig C. · EVP R&D, Chief Medical Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2020-02-21 Exercise or conversion : show line 1 in the form +6,875 15,955 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2020-02-21 Exercise or conversion : show line 2 in the form Restricted Stock Unit Award −6,875 20,625 D
Loading xslF345X03/form4a.xml…